Cited by 190Atrial Fibrillation Management and OutcomesInflammatory Biomarkers in Disease PrognosisCardiac electrophysiology and arrhythmias

Update on the Association of Inflammation and Atrial Fibrillation

PATEL, PARAG, DOKAINISH, HISHAM, TSAI, PETER, LAKKIS, NASSER·2010·Journal of Cardiovascular Electrophysiology

Abstract

Update on the Association of Inflammation and Atrial Fibrillation . Atrial fibrillation (AF) is a common arrhythmia and is associated with significant morbidity and mortality. The pathogenesis of AF remains incompletely understood and management remains a difficult task. Over the past decade there has been accumulating evidence implicating inflammation in the pathogenesis of AF. Inflammation appears to play a significant role in the initiation and perpetuation of AF as well as the prothrombotic state associated with AF. Inflammatory biomarkers (C‐reactive protein and interleukin‐6) have been shown to be associated with the future development, recurrence and burden of AF, and the likelihood of successful cardioversion. Therapies directed at attenuating the inflammatory burden appear promising. Animal and clinical studies have evaluated statins, angiotensin‐converting enzyme inhibitors/angiotensin‐II receptor blockers, and corticosteroids for the treatment or prevention of AF. The purpose of this review is to provide current evidence on the relationship between inflammation and AF and potential therapies available to modulate the inflammatory state in AF. (J Cardiovasc Electrophysiol, Vol. 21, pp. 1064‐1070, September 2010)

Integrity signals

Registry

Crossref · 10.1111/j.1540-8167.2010.01774.x

Cites

90 of 90 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In women aged <65 years with lone AF, the rate of thromboembolism varies widely, from 0.1-0.2% annual stroke risk in a Swedish study to 1.24/100 person-years in a Danish study.

    “Notably, a nationwide register study of >120,000 individuals with AF in Denmark found a rate of thromboembolism as high as 1.24/100 person–years among women aged < 65 years with lone AF at 1-year follow-up.86 In contrast, however, a Swedish nationwide study of >140,000 individuals with AF showed that the annual stroke risk for women with AF who were aged <65 years was 0.1–0.2%.85”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
PATEL, P., DOKAINISH, H., TSAI, P., & LAKKIS, N.
Affiliations
  • Baylor College of Medicine (US)
  • McMaster University (CA)
Corresponding author
LAKKIS, NASSER
Venue
Journal of Cardiovascular Electrophysiology
Publisher
Wiley
Published
2010-09
Volume
21
Issue
9
Pages
1064-1070
ISSN
  • 1045-3873 (ISSN-L)
  • 1540-8167
OpenAlex
W1994315223
Cited by
190
References
90
Citations by year
2026: 7 · 2025: 12 · 2024: 14 · 2023: 9 · 2022: 14 · 2021: 15 · 2020: 17 · 2019: 7 · 2018: 16 · 2017: 10 · 2016: 17 · 2015: 13 · 2014: 8 · 2013: 7 · 2012: 11
FWCI
1.65
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Cardiovascular Electrophysiology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
  • Health Sciences › Medicine › Oncology › Inflammatory Biomarkers in Disease Prognosis
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
Keywords
atrial fibrillation, inflammation, inflammatory markers, C-reactive protein, interleukin-6, hypercoagulability, cardioversion, statins, ACE inhibitors, angiotensin receptor blockers, corticosteroids, anti-inflammatory therapy
MeSH terms
Animals, Anti-Arrhythmia Agents, Anti-Inflammatory Agents, Atrial Fibrillation, Humans, Inflammation, Risk Factors, Thromboembolism, Treatment Outcome, Inflammation Mediators

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review